Dissecting depression symptoms: Multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation
Brain, Behavior, and Immunity · 2025
DOI: 10.1016/j.bbi.2024.09.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von Jonas Hagenberg und 15 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; International Max Planck Research School for Translational Psychiatry,…. Hauptthemen laut MEDLINE: Depression, Biomarkers, Leukocytes, Mononuclear. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain and Behavior Research Foundation.
Themen: Depression
Abstract (Originalsprache)
In a subset of patients with mental disorders, such as depression, low-grade inflammation and altered immune marker concentrations are observed. However, these immune alterations are often assessed by only one data type and small marker panels. Here, we used a transdiagnostic approach and combined data from two cohorts to define subgroups of depression symptoms across the diagnostic spectrum through a large-scale multi-omics clustering approach in 237 individuals. The method incorporated age, body mass index (BMI), 43 plasma immune markers and RNA-seq data from peripheral mononuclear blood cells (PBMCs). Our initial clustering revealed four clusters, including two immune-related depression symptom clusters characterized by elevated BMI, higher depression severity and elevated levels of immune markers such as interleukin-1 receptor antagonist (IL-1RA), C-reactive protein (CRP) and C-C motif chemokine 2 (CCL2 or MCP-1). In contrast, the RNA-seq data mostly differentiated a cluster with low depression severity, enriched in brain related gene sets. This cluster was also distinguished by electrocardiography data, while structural imaging data revealed differences in ventricle volumes across the clusters. Incorporating predicted cell type proportions into the clustering resulted in three clusters, with one showing elevated immune marker concentrations. The cell type proportion and genes related to cell types were most pronounced in an intermediate depression symptoms cluster, suggesting that RNA-seq and immune markers measure different aspects of immune dysregulation. Lastly, we found a dysregulation of the SERPINF1/VEGF-A pathway that was specific to dendritic cells by integrating immune marker and RNA-seq data. This shows the advantages of combining different data modalities and highlights possible markers for further stratification research of depression symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; International Max Planck Research School for Translational Psychiatry, 80804 Munich, Germany; Institute of Computational Biology, Helmholtz…
- Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany.
- Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany. Electronic address: brueckl@psych.mpg.de.
- Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; International Max Planck Research School for Translational Psychiatry, 80804 Munich, Germany. Electronic address: mira_erhart@psych.mpg.de.
- Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; Department of Psychology, LMU Munich, Leopoldstr. 13, 80802 Munich, Germany. Electronic address: Kopf-Beck@psy.lmu.de.
- Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany. Electronic address: koedel@psych.mpg.de.
Förderung
- Brain and Behavior Research Foundation
Zitieren
APA
Hagenberg, J., BeCOME study group, OPTIMA study group, Brückl, T. M., Erhart, M., Kopf-Beck, J., Ködel, M., Rehawi, G., Röh-Karamihalev, S., Sauer, S., Yusupov, N., Rex-Haffner, M., Spoormaker, V. I., Sämann, P., Binder, E., & Knauer-Arloth, J. (2025). Dissecting depression symptoms: Multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.09.013
Vancouver
Hagenberg J, BeCOME study group, OPTIMA study group, Brückl TM, Erhart M, Kopf-Beck J, et al. Dissecting depression symptoms: Multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2024.09.013
BibTeX
@article{Hagenberg2025,
author = {Hagenberg, Jonas and BeCOME study group, BeCOME study group and OPTIMA study group, OPTIMA study group and Brückl, Tanja M and Erhart, Mira and Kopf-Beck, Johannes and Ködel, Maik and Rehawi, Ghalia and Röh-Karamihalev, Simone and Sauer, Susann and Yusupov, Natan and Rex-Haffner, Monika and Spoormaker, Victor I and Sämann, Philipp and Binder, Elisabeth and Knauer-Arloth, Janine},
title = {Dissecting depression symptoms: Multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation},
journal = {Brain, Behavior, and Immunity},
year = {2025},
doi = {10.1016/j.bbi.2024.09.013}
}
EUVIMED